This Viewpoint discusses the role of implementation and translational science and digital platforms for improving population cardiovascular risk and advancing precision treatments in an era of intensive statin therapy and PCSK9 inhibitors.
This Viewpoint reviews the myths about and makes recommendations for statin treatment.
This Viewpoint summarizes the findings and limitations of clinical trial evidence regarding the benefits and risks of statins for primary prevention of atherosclerotic cardiovascular disease in persons older than 75 years.
This Viewpoint discusses a cardiology episode-based payment model proposed by the Centers for Medicare & Medicaid Services to improve the quality and efficiency of cardiac care.
This randomized clinical trial comparing use of general anesthesia vs conscious sedation among patients with acute ischemic stroke in the anterior circulation undergoing thrombectomy, reports no significant difference in improvement of neurological status at 24-hour follow-up.
This Recommendation Statement from the US Preventive Services Task Force recommends use of low- to moderate-dose statins for primary prevention in adults aged 40 to 75 years who have 1 or more CVD risk factors and a calculated CVD event risk of 10% or greater (B recommendation).
This Evidence Report and systematic review to support the 2016 US Preventive Services Task Force Recommendation Statement on use of statins for prevention of cardiovascular disease (CVD) summarizes published trial evidence about the benefits and harms of statins for primary CVD prevention.
This study summarizes transfusion recommendations from the AABB (formerly known as the American Association of Blood Banks) based on randomized clinical trials.
This commentary discusses a randomized clinical trial published in JAMA Pediatrics that examined associations between responsive parenting and infant weight gain between birth and 28 weeks and overweight status.
This JAMA Clinical Guidelines Synopsis summarizes the UK National Clinical Guideline Centre’s 2015 guideline on transfusion of red blood cells.
This study uses data from 5 National Heart, Lung, and Blood Institute cohorts to investigate changes in association between modifiable risk factors and coronary heart disease from 1983-1995 and from 1996-2011.
This study describes the changes in characteristics of winners of the Noble Prize in Physiology or Medicine over time as well as their time to recognition.
This Medical News feature discusses the advances in clinical trial design and implementation that have grown out of the precision medicine approach.
Create a personal account or sign in to: